Tolera Therapeutics Inc — Form D
Tolera Therapeutics Inc of KALAMAZOO, MI, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-15. The offering totals $2.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-05-15
- Form: D
- Accession: 0001451072-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.5M
- Remaining: $535K
- Minimum investment: $10K
- Investors: 10
- Date of first sale: 2012-05-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-178252
Issuer
- Name: Tolera Therapeutics Inc
- CIK: 0001451072
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 350 EAST MICHIGAN AVENUE, KALAMAZOO, MI, 49007
- Phone: (269) 585-2100
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Mark Olesnavage | Director | Kalamazoo, MI |
| Donald Parfet | Director | Kalamazoo, MI |
| Ashleigh Palmer | Executive Officer | Waltham, MA |
| Douglas Morton | Director | Kalamazoo, MI |
| Suzette Dutch | Director | Kalamazoo, MI |
| John Puisis | Director | Kalamazoo, MI |
| John Puisis | Executive Officer | Kalamazoo, MI |
| James Herrmann | Executive Officer | Kalamazoo, MI |
Other filings by this issuer (6)
More